This guide intends to educate clinicians and other stakeholders about the harms of using more than one substance and consideration for addressing concurrent substance use (CSU) and concurrent substance use disorders (CSUD).
Dashboard: Filter Bricks
Main page content
![](/sites/default/files/styles/product_thumbnail_dashboard/public/pep21-02-01-003.png?itok=55xy8Ysh)
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
![](/sites/default/files/styles/product_thumbnail_dashboard/public/pep21-02-01-002.png?itok=6OxqiQyG)
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
![Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders](/sites/default/files/styles/product_thumbnail_dashboard/public/sma13-4785.jpg?itok=LUx9b-lV)
This manual serves as a quick reference guide for clinicians treating chronic pain in adults living with a history of substance use. It covers patient assessment and treatment, and provides an algorithm for managing chronic pain, as well as a summary of non-opioid analgesics.
![Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders](/sites/default/files/styles/product_thumbnail_dashboard/public/sma13-4792.jpg?itok=6Dj0Ds6X)
This quick guide summarizes guidelines for clinicians treating chronic pain in adults living with a history of substance misuse. It covers patient assessment, chronic pain management, managing addiction risk in patients treated with opioids, and patient education.